Search

Your search keyword '"Ghadimi, B. Michael"' showing total 529 results

Search Constraints

Start Over You searched for: Author "Ghadimi, B. Michael" Remove constraint Author: "Ghadimi, B. Michael"
529 results on '"Ghadimi, B. Michael"'

Search Results

151. Prognostic Value of MicroRNAs in Preoperative Treated Rectal Cancer.

153. The Rectal Cancer microRNAome – microRNA Expression in Rectal Cancer and Matched Normal Mucosa

155. Enrichment of CD133-expressing cells in rectal cancers treated with preoperative radiochemotherapy is an independent marker for metastasis and survival

156. HER2 status in locally advanced rectal cancer and metachronous metastases: Opportunity for a new therapeutic approach?

157. Resectability and indication for chemotherapy in patients with colorectal liver metastases as assessed by medical oncologists and surgeons.

159. Abstract 5005: Large-scale DNA methylation profiling in gastrointestinal stromal tumors (GIST) reveals epigenetic regulation of SPP1 as an independent prognostic factor

161. DPEP1 Inhibits Tumor Cell Invasiveness, Enhances Chemosensitivity and Predicts Clinical Outcome in Pancreatic Ductal Adenocarcinoma

165. Optimal Lymph Node Harvest in Rectal Cancer (UICC Stages II and III) after Preoperative 5-FU–based Radiochemotherapy. Acetone Compression is a New and Highly Efficient Method

166. Abstract 2490: Silencing of TCF7L2 sensitizes Wnt/β-catenin signaling-dependent colorectal cancer cells to radiation

167. Abstract 2508: Identification of potential relevant pathways and genes for resistance to chemoradiotherapy in colorectal cancer cells

168. Failure of Downregulation of Survivin Following Neoadjuvant Radiochemotherapy in Rectal Cancer Is Associated with Distant Metastases and Shortened Survival

169. A Gene Expression Signature for Chemoradiosensitivity of Colorectal Cancer Cells

171. Mutated KRAS results in overexpression of DUSP4, a MAP-kinase phosphatase, and SMYD3, a histone methyltransferase, in rectal carcinomas

172. A genomic strategy for the functional validation of colorectal cancer genes identifies potential therapeutic targets

174. Abstract 247: A functional genomics and a systems biology approach identify POMP as a potential therapeutic target for colorectal cancer

176. Solitary Cutaneous Nodule of Blastic Plasmacytoid Dendritic Cell Neoplasm Progressing to Overt Leukemia Cutis After Chemotherapy: Immunohistology and FISH Analysis Confirmed the Diagnosis

179. Chromosomal Breakpoints in Primary Colon Cancer Cluster at Sites of Structural Variants in the Genome

180. Autorenverzeichnis

181. Gene Expression Profiling Reveals a Massive, Aneuploidy-Dependent Transcriptional Deregulation and Distinct Differences between Lymph Node–Negative and Lymph Node–Positive Colon Carcinomas

182. Combined DNA methylation and gene expression profiling in gastrointestinal stromal tumors reveals hypomethylation of SPP1 as an independent prognostic factor.

184. Aneuploidy-Dependent Massive Deregulation of the Cellular Transcriptome and Apparent Divergence of the Wnt/β-catenin Signaling Pathway in Human Rectal Carcinomas

195. Amplification of 4q21-q22 and theMXR gene in independently derived mitoxantrone-resistant cell lines

198. STAT3 inhibition sensitizes colorectal cancer to chemoradiotherapy in vitro and in vivo.

199. PAM4 enzyme immunoassay alone and in combination with CA 19-9 for the detection of pancreatic adenocarcinoma.

200. Enrichment of CD133-expressing cells in rectal cancers treated with preoperative radiochemotherapy is an independent marker for metastasis and survival.

Catalog

Books, media, physical & digital resources